The Safety and Effectiveness of mRNA Vaccines Against SARS-CoV-2

The coronavirus disease 2019 (COVID-19) pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in numerous deaths worldwide, along with devastating economic disruptions, and has posed unprecedented challenges to healthcare systems around the world. I...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Curēus (Palo Alto, CA) CA), 2023-09, Vol.15 (9), p.e45602-e45602
Hauptverfasser:	Jamous, Yahya F, Alhomoud, Dalal A
Format:	Artikel
Sprache:	eng
Schlagworte:	Allergy/Immunology Clinical trials COVID-19 vaccines Disease transmission Epidemiology/Public Health Good Manufacturing Practice Immune system Infectious Disease International organizations Lipids mRNA vaccines Pandemics Peptides Polyethylene glycol Proteins RNA polymerase Severe acute respiratory syndrome coronavirus 2 Stem cells
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!